Vivos Therapeutics (VVOS) FCF Margin Growth (1y) (2021 - 2026)
Powered by 
Analysis
Vivos Therapeutics (VVOS) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn | 429.00 |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | 308.00 |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn | 409.00 |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn | 4,976.00 |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | - |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn | 4,183.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,183.00 |
| Mar 31, 2026 | 1,279.00 |
| Dec 31, 2025 | -13,090.00 |
| Sep 30, 2025 | 5,309.00 |
| Jun 30, 2025 | -3,425.00 |
| Mar 31, 2025 | -5,203.00 |
| Dec 31, 2024 | 674.00 |
| Sep 30, 2024 | -2,429.00 |
| Jun 30, 2024 | 1,393.00 |
| Mar 31, 2024 | 1,995.00 |
| Dec 31, 2023 | -861.00 |
| Sep 30, 2023 | 5,076.00 |
| Jun 30, 2023 | 3,158.00 |
| Mar 31, 2023 | 7,274.00 |
| Dec 31, 2022 | 2,149.00 |
| Sep 30, 2022 | -4,227.00 |
| Jun 30, 2022 | -1,163.00 |
| Mar 31, 2022 | -4,998.00 |
| Dec 31, 2021 | 1,039.00 |
| Sep 30, 2021 | -7,712.00 |